Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
MedPal AILSE:MPAL Market Cap is £23.87 Mil as of Aug. 04, 2026. The stock has 1 warning sign investors should review. Among 692 Healthcare Providers & Services companies, MedPal AI ranks worse than 69.08% on this metric.
Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). MedPal AI's share price for the quarter that ended in Feb. 2026 was £0.04375. MedPal AI's Shares Outstanding (EOP) for the quarter that ended in Feb. 2026 was 455.16 Mil. Therefore, MedPal AI's market cap for the quarter that ended in Feb. 2026 was £19.91 Mil.
MedPal AI's quarterly market cap
increased
from Feb. 2025 (£0.00 Mil) to Aug. 2025 (£29.95 Mil) but then
declined
from Aug. 2025 (£29.95 Mil) to Feb. 2026 (£19.91 Mil).
MedPal AI's annual market cap
stayed the same
from Aug. 2023 (£0.00 Mil) to Aug. 2024 (£0.00 Mil) but then
increased
from Aug. 2024 (£0.00 Mil) to Aug. 2025 (£29.95 Mil).
Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. MedPal AI's Enterprise Value for Today is £24.61 Mil.
Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the companys debt. The real price you pay is the Enterprise Value.
Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.
MedPal AI Market Cap Related Terms
MedPal AI Market Cap Historical Data
* Premium members only.
The historical data trend for MedPal AI's Market Cap can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
LSE:MPAL vs VEEV, BTSG, HQY: Market Cap Comparison
For the Health Information Services subindustry, MedPal AI's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
MedPal AI Market Cap vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, MedPal AI's Market Cap distribution charts can be found below:
* The bar in red indicates where MedPal AI's Market Cap falls into.
Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.
MedPal AI's Market Cap for the fiscal year that ended in Aug. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
MedPal AI (LSE:MPAL) has a Market Cap of £23.87 Mil as of Aug. 04, 2026. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on MedPal AI and its competitors. According to the industry distribution chart, MedPal AI ranks #478 out of 692 companies in the Healthcare Providers & Services industry, placing it in the top 69.1%.
Is MedPal AI's Market Cap too high?
MedPal AI's current Market Cap is £23.87 Mil. Based on the distribution chart, MedPal AI ranks #478 out of 692 companies in the Healthcare Providers & Services industry, which is below the industry midpoint.
How does MedPal AI's Market Cap compare to VEEV and BTSG?
According to the Healthcare Providers & Services industry distribution chart, MedPal AI ranks #478 out of 692 companies for Market Cap. This places MedPal AI in the lower half of its industry. The industry median Market Cap is 104.33. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Market Cap for a Healthcare Providers & Services company?
The median Market Cap among Healthcare Providers & Services companies is 104.33, based on 692 companies in the industry. Companies in the top quartile (top 25%) have a Market Cap significantly above this median, while those in the bottom quartile fall well below. However, Market Cap should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Market Cap mean?
A high Market Cap can signal that a stock is expensive relative to its fundamentals. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on MedPal AI and its competitors. For the Healthcare Providers & Services industry, the median Market Cap is 104.33 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. MedPal AI's current Market Cap is £23.87 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is MedPal AI stock overvalued right now?
MedPal AI (LSE:MPAL) has a current Market Cap of £23.87 Mil. The current Market Cap is £23.87 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Market Cap calculated?
Market Cap is calculated from a company's financial statements. For MedPal AI (LSE:MPAL), the current Market Cap is £23.87 Mil as of Aug. 04, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
MedPal AI PLC is a UK-based digital health and artificial intelligence company focused on the development and commercialisation of AI-enabled healthcare platforms.. Its platform aggregates data across devices and apps (including Apple Health, Fitbit, Garmin, and Google Fit) to deliver real-time, personalized health insights. The Company has two reportable segments, Software and Corporate.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
LSE:MPAL has been successfully added to your 
